C. Lupfer, Patton, K. M., and Pastey, M.
, “Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality.”
, vol. 268, no. 1-2, pp. 25-30, 2010.
M. Pastey, Gower, T. L., Spearman, P. W., Crowe, J. E., and Graham, B. S.
, “A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3.”
, Nature medicine
, vol. 6, no. 1, pp. 35-40, 2000.
M. Maselko, Ward, C., and Pastey, M.
, “A RhoA-derived peptide inhibits human immunodeficiency virus-1 entry in vitro.”
, Current HIV research
, vol. 9, no. 1, pp. 1-5, 2011.
T. L. Gower, Pastey, M., Peeples, M. E., Collins, P. L., McCurdy, L. H., Hart, T. K., Guth, A., Johnson, T. R., and Graham, B. S.
, “RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology.”
, Journal of virology
, vol. 79, no. 9, pp. 5326-36, 2005.
M. Pastey, Crowe, J. E., and Graham, B. S.
, “RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation.”
, Journal of virology
, vol. 73, no. 9, pp. 7262-70, 1999.
S. K. Samal, Pastey, M., McPhillips, T., Carmel, D. K., and Mohanty, S. B.
, “Reliable confirmation of antibodies to bovine respiratory syncytial virus (BRSV) by enzyme-linked immunosorbent assay using BRSV nucleocapsid protein expressed in insect cells.”
, Journal of clinical microbiology
, vol. 31, no. 12, pp. 3147-52, 1993.
K. A. Reese, Lupfer, C., Johnson, R. C., Mitev, G. M., Mullen, V. M., Geller, B. L., and Pastey, M.
, “A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated Chickens.”
, Veterinary medicine international
, vol. 2013, p. 316926, 2013.
Q. Ge, Pastey, M., Kobasa, D., Puthavathana, P., Lupfer, C., Bestwick, R. K., Iversen, P. L., Chen, J., and Stein, D. A.
, “Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.”
, Antimicrobial agents and chemotherapy
, vol. 50, no. 11, pp. 3724-33, 2006.
C. Lupfer, Stein, D. A., Mourich, D. V., Tepper, S. E., Iversen, P. L., and Pastey, M.
, “Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers.”
, Archives of virology
, vol. 153, no. 5, pp. 929-37, 2008.
C. Lupfer, Besnouin, D., Tepper, S. E., Maselko, M., Patton, K. M., and Pastey, M.
, “Increased Survivorship and Altered Cytokine Profile from Treatment of Influenza A H1N1-Infected Mice with Ekybion: A Drug Complex of Natural Extracts and Inorganic Compounds.”
, Evidence-based complementary and alternative medicine : eCAM
, vol. 2011, p. 192079, 2011.
E. C. McKenzie, Lupfer, C., Banse, H., Hinchcliff, K., Love, S., Nelson, S., Davis, M., Payton, M., and Pastey, M.
, “Hypogammaglobulinemia in racing Alaskan sled dogs.”
, Journal of veterinary internal medicine / American College of Veterinary Internal Medicine
, vol. 24, no. 1, pp. 179-84, 2010.
S. Mohapatra, Park, S. J., Boyapalle, S., Pastey, M., Graham, B. S., and Blanck, G.
, “Human respiratory syncytial virus reduces the number of cells in S-phase and increases GADD153 expression in HEp-2 cells.”
, Acta virologica
, vol. 53, no. 3, pp. 207-11, 2009.
S. K. Samal, Pastey, M., McPhillips, T. H., and Mohanty, S. B.
, “Bovine respiratory syncytial virus nucleocapsid protein expressed in insect cells specifically interacts with the phosphoprotein and the M2 protein.”
, vol. 193, no. 1, pp. 470-3, 1993.